Page 142 - THE EVOLUTION OF EARLY ARTHRITIS AND CARDIOVASCULAR RISK Samina A. Turk

CHAPTER 7
140
RAID physical well- being (0-10)
RAID emotional well- being (0-10)
4.0 [2.0-7.0] 5.0 [2.0-7.0]
5.0 [3.0-7.0]†
3.0 2.0
[1.0-5.0] * [0.0-5.0] *
RAID coping (0-10)
5.0 [2.0-7.0]
3.0 [1.3-7.0]
5.0 [3.0-7.3]
2.0 0.2
[0.0-4.0] * [0.0-0.6] *
0.5 [0.0-2.0] 0.0 [0.0-0.3]
3.0 [2.0-5.0]‡ 0.5 [0.1-0.9]‡
Baseline values Total population n=84
Values after 12 weeks of treatment
0.8 [0.3-1.3]
Numbers are presented as mean (SD) or median [IQR] unless otherwise stated.
HAQ (0-3)
0.9 [0.5-1.5]
1.3 [0.6-0.8]†
Patients in
self- perceived remission at week 12, n=45
3.0 [1.3-6.0]
Patients not in self- Total population, perceived remission n=84
at week 12, n=39
Patients in self- perceived remission at week 12, n=45 1.0 [0.0-3.0]
Patients not in self- perceived remission at week 12, n=39 4.0 [2.0-5.0]‡
5.0 [1.3-6.8]
6.0 [3.0-8.0]
1.0 [0.0-3.0]
4.0 [2.0-6.0]‡
*significant improvement (p<0.05) for the total population, between baseline and 12 weeks after treatment.
† significant difference (p<0.05) in baseline values between patient in and patient not in self-perceived remission after 12 weeks of treatment
‡ significant difference (p<0.05) in week 12 values between patients in and patient not in self-perceived remission after 12 weeks of treatment
ACPA: anti-citrullinated protein, CRP: C-reactive protein, DAS44: disease activity score of 44 joints, ESR: erythrocyte sedimentation rate, FDA: functional disability assessment, HAQ: Health Assessment Questionnaire, IQR: interquartile range, l: liter, mg: milligram, mm: millimeter, n:number, RAID: Rheumatoid Arthritis Impact of Disease questionnaire, RF: rheumatoid factor, SD: standard deviation, SJC44: swollen joint count of 44 joints, TJC44: tender joint count of 44 joints, VAS: visual analogue scale